The NANETS Consensus Guidelines for the Diagnosis and Management of Poorly Differentiated (High-Grade) Extrapulmonary Neuroendocrine Carcinomas

Por Strosberg, Jonathan R., Coppola, Domenico, Klimstra, David S., Phan, Alexandria T., Kulke, Matthew H., Wiseman, Gregory A., Kvols, Larry K.
Publicado em 2010

Progress in Gene Therapy for Prostate Cancer

Por Ahmed, Kamran A., Davis, Brian J., Wilson, Torrence M., Wiseman, Gregory A., Federspiel, Mark J., Morris, John C.
Publicado em 2012

Liver transplantation after radioembolization in a patient with unresectable HCC

Por Moreno Luna, Laura E., Kwo, Paul Y., Roberts, Lewis R., Mettler, Teresa A., Gansen, Denise N., Andrews, James C., Wiseman, Gregory A., Misra, Vijay Laxmi
Publicado em 2009

Use of Positron Emission Tomography-Computerized Tomography (PET-CT) in the Management of Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL)

Por Conte, Michael J., Bowen, Deborah A., Wiseman, Gregory A., Rabe, Kari G., Slager, Susan L., Schwager, Susan M., Call, Timothy G., Viswanatha, David S., Zent, Clive S.
Publicado no Leuk Lymphoma (2014)

Usefulness of (123)I-MIBG Scintigraphy in the Evaluation of Patients with Known or Suspected Primary or Metastatic Pheochromocytoma or Paraganglioma: Results from a Prospective Mul...

Por Wiseman, Gregory A., Pacak, Karel, O’Dorisio, Mary S., Neumann, Donald R., Waxman, Alan D., Mankoff, David A., Heiba, Sherif I., Serafini, Aldo N., Tumeh, Sabah S., Khutoryansky, Natalie, Jacobson, Arnold F.
Publicado no J Nucl Med (2009)

Epratuzumab with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated diffuse large B-cell lymphoma

Por Micallef, Ivana N. M., Maurer, Matthew J., Wiseman, Gregory A., Nikcevich, Daniel A., Kurtin, Paul J., Cannon, Michael W., Perez, Domingo G., Soori, Gamini S., Link, Brian K., Habermann, Thomas M., Witzig, Thomas E.
Publicado em 2011

A phase I multiple dose, dose escalation study of cG250 monoclonal antibody in patients with advanced renal cell carcinoma

Por Davis, Ian D., Wiseman, Gregory A., Lee, Fook-Thean, Gansen, Denise N., Hopkins, Wendie, Papenfuss, Anthony T., Liu, Zhanqi, Moynihan, Timothy J., Croghan, Gary A., Adjei, Alex A., Hoffman, Eric W., Ingle, James N., Old, Lloyd J., Scott, Andrew M.
Publicado em 2007

A Phase I Trial of Immunostimulatory CpG 7909 Oligodeoxynucleotide and (90)Yttrium Ibritumomab Tiuxetan Radioimmunotherapy for Relapsed B-cell Non-Hodgkin Lymphoma

Por Witzig, Thomas E., Wiseman, Gregory A., Maurer, Matthew J., Habermann, Thomas M., Micallef, Ivana N. M., Nowakowski, Grzegorz S., Ansell, Stephen M., Colgan, Joseph P., Inwards, David J., Porrata, Luis F., Link, Brian K., Zent, Clive S., Johnston, Patrick B., Shanafelt, Tait D., Allmer, Cristine, Asmann, Yan W., Gupta, Mamta, Ballas, Zuhair K., Smith, Brian J., Weiner, George J.
Publicado em 2013

Efficacy and Safety of Transarterial Radioembolization Versus Chemoembolization in Patients With Hepatocellular Carcinoma

Por Moreno-Luna, Laura E., Yang, Ju Dong, Sanchez, William, Paz-Fumagalli, Ricardo, Harnois, Denise M., Mettler, Teresa A., Gansen, Denise N., de Groen, Piet C., Lazaridis, Konstantinos N., Narayanan Menon, K. V., LaRusso, Nicholas F., Alberts, Steven R., Gores, Gregory J., Fleming, Chad J., Slettedahl, Seth W., Harmsen, William S., Therneau, Terry M., Wiseman, Gregory A., Andrews, James C., Roberts, Lewis R.
Publicado em 2012